Bacterial Vaginosis During Pregnancy: Current State of the Problem and the Role of Antimicrobial Chemotherapy | CMAC

Bacterial Vaginosis During Pregnancy: Current State of the Problem and the Role of Antimicrobial Chemotherapy

Clinical Microbiology and Antimicrobial Chemotherapy. 2007; 9(4):337-350

​ Reshetko O.V., Lucevich K.A.
bacterial vaginosis pregnancy diagnosis etiology treatment
Section
Diseases and Pathogens
Type
Journal article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2007; 9(4):337-350

Abstract

Pregnancy is an important risk factor for the development of bacterial vaginosis. According to the data of epidemiological studies, the prevalence of this disorder in pregnant women varies from 10% to 40% in different countries. In USA estimated population risk of preterm delivery related to bacterial vaginosis comes to 30% and value at $ 1 billion annually. In the present article the etiology and epidemiology of bacterial vaginosis are described in details. Special attention is paid to the discussion of available treatment options.

  • 1. Koumans E.H., Kendrick J.S. Preventing adverse sequelae of bacterial vaginosis:a public health program and research agenda. Sex Transm Dis 2001; 28:292-7.
  • 2. Malm H., Martikainen J., Klaukka T., Neuvonen J. Prescription drugs during pregnancy and lactation – a Finnish register-based study. Eur J Clin Pharmacol 2003; 59:127-33.
  • 3. Egen-Lappe V., Hasford J. Drug prescription in pregnancy:analysis of a large statutory sickness fund population. Eur J Clin Pharmacol 2004; 60:659-66.
  • 4. Lacroix I., Damase-Michel C., Lapeyre-Mestre M., Montastruc J.L. Prescription of drugs during pregnancy in France. Lancet 2000; 356:1735-6.
  • 5. Olesen C., Steffensen F.H., Nielson L.G., et al. Drug use in first pregnancy and lactation:a population-based survey among Danish women. Eur J Clin Pharmacol 1999; 55:139-44.
  • 6. Kekki M., Kurki T., Pelkonen J., et al. Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis:a randomized, controlled trial. Obstet Gynecol 2001; 97:643-8.
  • 7. Vermeulen G.M., van Zwet A.A., Bruinse H.W. Changes in the vaginal flora after two percent clindamycin vaginal cream in women at high risk of spontaneous preterm birth. Br J Obstet Gynaecol 2001; 108:697-700.
  • 8. Peipert J.F., Montagno A.G., Cooper A.S., Sung C.J. Bacterial vaginosis as a risk factor for upper genital tract infection. Am J Obstet Gynecol 1997; 177:1184-7.
  • 9. Goldenberg R.L., Hauth J.C. Andrews W.W. Intrauterine infection and preterm delivery. N Engl J Med 2000; 342:1500-7.
  • 10. Govender L., Hoosen A.A., Moodley J., et al. Bacterial vaginosis and associated infections in pregnancy. Int J Gynaecol Obstet 1996; 55:23-8.
  • 11. Hay P.E., Lamont R.F., Taylor-Robinson D., et al. Abnormal bacterial colonization of the genital tract and subsequent preterm delivery and late miscarriage. Br Med J 1994; 308:295-8.
  • 12. Hillier S.L., Nugent R.P., Eschenbach D.A., et al. Association between bacterial vaginosis and preterm delivery of a lowbirth-weight infant. N Engl J Med 1995; 333:1737-42.
  • 13. Minkoff H., Grunebaum A.N., Schwarz R.H., et al. Risk factors for prematurity and premature rupture of membranes:a prospective study of vaginal flora in pregnancy. Am J Obstet Gynecol 1984; 150:965-72.
  • 14. McGregor J.A., French J.I., Parker R., et al. Prevention of premature birth by screening and treatment of common genital tract infections:results of a prospective controlled evaluation. Am J Obstet Gynecol 1995; 173:157-67.
  • 15. Ralph S.G., Rutherford A.J., Wilson J.D. Influence of bacterial vaginosis on conception and miscarriage in the first trimester cohort study. Br Med J 1999; 319:220-3.
  • 16. Hillier S.L., Martius J., Krohn M., et al. A case-control study of chorioamnionic infection and histological chorioamnionitis in prematurity. N Engl J Med 1988; 319:972-8.
  • 17. Gibbs R. Chorioamnionitis and bacterial vaginosis. Am J Obstet Gynecol 1993; 169:460-3.
  • 18. Hillier S., Kiviat N.B., Hawes S.E., et al. Role of bacterial vaginosis-associated microorganisms in endometritis. Am J Obstet Gynecol 1996; 175:435-41.
  • 19. Прилепская В.Н., Байрамова Г.Р. Этиопатогенез, диагностика и современные направления в лечении бактериального вагиноза. РМЖ 2002; 18:795-7.
  • 20. Bhutta Z.A., Darmstadt G.L., Hasan B.S., Haws R.A. Community-based interventions for improving perinatal and neonatal health outcomes in developing countries:A review of the evidence. Pediatrics 2005; 115:519-617.
  • 21. McGregor J.A., French J.I. Bacterial vaginosis in pregnancy. Obstet Gynecol Surv 2000; 55(Suppl. 1):1-19.
  • 22. Rauh V.A., Culhane J.F., Hogan V.K. Bacterial vaginosis: a public health problem for women. J Am Med Womens Assoc 2000; 55:220-2.
  • 23. Kurki T., Sivonen A., Renkonen O.V., et al. Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol 1992; 80:173-7.
  • 24. Cristiano L., Rampello S., Noris C., et al. Bacterial vaginosis:prevalence in an Italian population of asymptomatic pregnant women and diagnostic aspects. Eur J Epidemiol 1996; 12:383-90.
  • 25. Kiss H., Petricevic L., Husslein P. Prospective randomized controlled trial of an infection screening programme to reduce the rate of preterm delivery. Br Med J 2004; 329:371-5.
  • 26. Hay P.E., Morgan D.J., Ison C.A., et al. A longitudinal study of bacterial vaginosis during pregnancy. Br J Obstet Gynaecol 1994; 101:1048-53.
  • 27. Oakeshott P., Hay P., Hay S., et al. Association between bacterial vaginosis or chlamydial infection and miscarriage before 16 weeks’ gestation:prospective community based cohort study. Br Med J 2002; 325:1334-8.
  • 28. Nelson D.B., Macones G. Bacterial vaginosis in pregnancy:current findings and future directions. Epidemiol Rev 2002; 24:102-8.
  • 29. Schmid G.P. The epidemiology of bacterial vaginosis. Int J Gynaecol Obstet 1999; 67:S17-S20.
  • 30. Goldenberg R.L., Klebanoff M.A., Nugent R., et al. Bacterial colonization of the vagina during pregnancy in four ethnic groups:vaginal infections and prematurity study group. Am J Obstet Gynecol 1996; 174:1618-21.
  • 31. Culhane J.F., Rauth V., McCollum K.F., et al. Maternal stress is associated with bacterial vaginosis in human pregnancy. Matern Child Health 2001; 5:127-34.
  • 32. Culhane J.F., Rauth V., McCollum K.F., et al. Exposure to chronic stress and ethnic differences in rates of bacterial vaginosis among pregnant women. Am J Obstet Gynecol 2002; 187:1272-6.
  • 33. Harville E.W., Hatch M.C., Zhang J. Perceived life stress and bacterial vaginosis. J Womens Health (Larchmt) 2005; 14:627-33.
  • 34. Harville E.W., Savitz D.A., Dole N., et al. Psychological and biological markers of stress and bacterial vaginosis in pregnant women. Br J Obstet Gynaecol 2007; 114:216-23.
  • 35. Ruiz R.J., Fullerton J., Brown C.E., Schoolfield J. Relationships of cortisol, perceived stress, genitourinary infections, and fetal fibronectin to gestational age at birth. Biol Res Nurs 2001; 3:39-48.
  • 36. Hay P.E. Recurrent bacterial vaginosis. Sex Transm Dis 1998; 16:769-73.
  • 37. McDonald H.M., O’Loughlin J.A., Vigneswaran R., et al. Bacterial vaginosis in pregnancy and efficacy of short-course oral metronidazole treatment:a randomized placebo controlled trial. Obstet Gynecol 1994; 84:343-8.
  • 38. Carey J.C., Klebanoff K., Hauth J., et al. Metronidazole to prevent preterm delivery in pregnancy women with asymptomatic bacterial vaginosis. N Engl J Med 2000; 342:534-40.
  • 39. Yudin M.H., Landers D.V., Meyn L., Hillier S.L. Clinical and cervical cytokine response to treatment with oral or vaginal metronidazole for bacterial vaginosis during pregnancy:a randomized trial. Obstet Gynecol 2003; 102:527-34.
  • 40. Hauth J.C., Goldenberg R.L., Andrews W.W., et al. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995; 333:1732-6.
  • 41. Centers for Disease Control and Prevention. Sexually transmitted disease treatment guidelines. MMWR Morb Mortal Wkly Rep 1997; 46:72-3.
  • 42. Burtin P., Taddio A., Artburnu O., et al. Safety of metronidazole in pregnancy:a meta-analysis. Am J Obstet Gynecol 1995; 172:525-9.
  • 43. Thapa P.B., Whitlock J.A., Brockman W.K.G., et al. Prenatal exposure to metronidazole and risk of childhood cancer:a retrospective cohort study of children younger than 5 years. Cancer 1998; 83:1461-8.
  • 44. Ugwumadu A., Reid F., Hay P., Manyonda I. Natural history of bacterial vaginosis and intermediate flora in pregnancy and effect of oral clindamycin. Obstet Gynecol 2004; 104:114-9.
  • 45. Joesoef M.R., Hillier S.L., Wiknjosastro G., et al. Intravaginal clindamycin treatment for bacterial vaginosis:effects on preterm delivery and low birth weight. Am J Obstet Gynecol 1995; 173:1527-31.
  • 46. Shennan A., Crawshaw S., Briley A., et al. A randomized controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin:the PREMET Study. Br J Obstet Gynaecol 2006; 113:65-74.
  • 47. Lettieri L., Vintzileos A.M., Rodis J.F., et al. Does “idiopathic” preterm labor resulting in preterm birth exist? Am J Obstet Gynecol 1993; 168:1480-5.
  • 48. Meis P.J., Goldenberg R.L., Mercer B., et al. The preterm prediction study:significance of vaginal infections. Am J Obstet Gynecol 1995; 173:1231-5.
  • 49. Holst E., Goffeng A.R., Andersch B. Bacterial vaginosis and vaginal microorganisms in idiopathic premature labor and association with pregnancy outcome. J Clin Microbiol 1994; 32:176-86.
  • 50. Martius J., Krohn M.A., Hillier S.L., et al. Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol 1988; 71:89-95.
  • 51. Goldenberg R.L., Iams J.D., Mercer B.M., et al. The Preterm Prediction Study:the value of new vs standard risk factors in predicting early and all spontaneous preterm births. Am J Public Health 1998; 88:233-8.
  • 52. Purwar M., Ughade S., Bhagat B., et al. Bacterial vaginosis in early pregnancy and adverse pregnancy outcome. J Obstet Gynecol Res 2001; 27:175-81.
  • 53. Gravett M.C., Nelson P., DeRouenn T., et al. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA 1986; 256:1899-903.
  • 54. Riduan J.M., Hillier S.L., Utomo B., et al. Bacterial vaginosis and prematurity in Indonesia:association in early and late pregnancy. Am J Obstet Gynecol 1993; 169: 175-8.
  • 55. Wennerholm U.B., Holm B., Mattsby-Baltzer I., et al. Fetal fibronectin, endotoxin, bacterial vaginosis and cervical length as predictors of preterm birth and neonatal morbidity in twin pregnancies. Br J Obstet Gynaecol 1997; 104:1398-404.
  • 56. McGregor J.A., French J.I., Jones W., et al. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase:results of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol 1994; 170:1048-60.
  • 57. Mullick S., Watson-Jones D., Beksinska M., et al. Sexually transmitted infections in pregnancy:prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries. Sex Transm Infect 2005; 81:294-302.
  • 58. Donders G.G., Van Bulck B., Caudron J., et al. Relationship of bacterial vaginosis and mycoplasmas to the risk of spontaneous abortion. Am J Obstet Gynecol 2000; 183:431-7.
  • 59. Liversedge N., Turner A. Horner P.J., et al. The influence of bacterial vaginosis on in vitro fertilization and embryo implantation during assisted reproduction treatment. Hum Reprod 1999; 14:2411-5.
  • 60. Korn A.P., Bolan G., Padian N., et al. Plasma cell endometritis in women with symptomatic bacterial vaginosis. Obstet Gynecol 1995; 85:387-90.
  • 61. French J. I., McGregor J. A., Draper D., et al. Gestational bleeding, bacterial vaginosis, and common reproductive tract infections:risk for preterm birth and benefit of treatment. Obstet Gynecol 1999; 93:715-24.
  • 62. Morales W.J., Schorr S., Albritton J. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis:a placebo-controlled, doubleblind study. Am J Obstet Gynecol 1994; 171:345-9.
  • 63. Chin B.M., Lamont R.F. The microbiology of preterm labor and delivery. Contemp Rev Obstet Gynaecol 1997; 9:285-96.
  • 64. Gratocos E., Figueras F., Barranco M., et al. Spontaneous recovery of bacterial vaginosis during pregnancy is not associated with an improved perinatal outcome. Acta Obstet Gynecol Scand 1998; 77:37-40.
  • 65. Rosenstein I.J., Morgan D.J., Lamont R.F., et al. Effect of intravaginal clindamycin cream on pregnancy outcome and on abnormal vaginal microbial flora of pregnant women. Infect Dis Obstet Gynecol 2000; 8:158-65.
  • 66. Nugent R.P., Krohn M.A., Hillier S.L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 1991; 29:297-301.
  • 67. Donders G.G., Bosmans E., Dekeersmaecker A., et al. Pathogenesis of abnormal vaginal bacterial flora. Am J Obstet Gynecol 2000; 182:872-8.
  • 68. Rosenstein I.J., Morgan D.J., Sheehan M., et al. Bacterial vaginosis in pregnancy:Distribution of bacterial species in different gram-stain categories of the vaginal flora. J Med Microbiol 1996; 45:120-6.
  • 69. Thorsen P., Jensen I.P., Jeune B., et al. Few microorganisms associated with bacterial vaginosis may constitute the pathologic core:a population-based microbiologic study among 3596 pregnant women. Am J Obstet Gynecol 1998; 178:580-7.
  • 70. Delaney M.L., Onderdonk A.B. Nugent score related to vaginal culture in pregnant women. Obstet Gynecol 2001; 98:79-84.
  • 71. Cauci S., Scrimin F., Driussi S., et al. Specific immune response against Gardnerella vaginalis hemolysin in patients with bacterial vaginosis. Am J Obstet Gynecol 1996; 187:877-81.
  • 72. Onderdonk A.B., Lee M.L., Lieberman E., et al. Quantitative microbiologic models for preterm delivery. J Clin Microbiol 2003; 41:1073-9.
  • 73. Usui R., Ohkuchi A., Matsubara S., et al. Vaginal lactobacilli and preterm birth. J Perinat Med 2002; 30:458-66.
  • 74. Wilks M., Wiggins R., Whiley A., et al. Identification and H2O2 production of vaginal lactobacilli from pregnant women at high risk of preterm birth and relation with outcome. J Clin Microbiol 2004; 42:713-7.
  • 75. Vallor A.C., May A.M.A., Hawes S.E., Hillier S.L. Factors associated with acquisition of or persistent colonization by, vaginal lactobacilli:role of hydrogen peroxide production. J Infect Dis 2001; 184:1431-6.
  • 76. Welsh A., Nicolaides K. Cervical screening for preterm delivery. Curr Opin Obstet Gynecol 2002; 14:195-202.
  • 77. Goldenberg R.L., Iams J.D., Mercer B.M., et al. The Preterm Prediction Study:toward a multiple-marker test for spontaneous pre-term birth. Am J Obstet Gynecol 2001; 185:643-51.
  • 78. Honest H., Bachmann L.M., Gupta J.K., et al. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth:systematic review. Br Med J 2002; 325:301-11.
  • 79. Goldenberg R.L., Mercer B.M., Meis P.J., et al. The preterm prediction study:fetal fibronectin testing and spontaneous preterm birth. Obstet Gynecol 1996; 87:643-8.
  • 80. Hellemans P., Gerris J., Verdonk P. Fetal fibronectin detection for prediction of preterm birth in low risk women. Br J Obstet Gynaecol 1995; 102:207-12.
  • 81. Lockwood C.J., Senyei A.E., Dische M.R., et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991; 325:66-74.
  • 82. Iams J.D., Casal D., McGregor J.A., et al. Fetal fibronectin improves the accuracy of diagnosis of preterm labor. Am J Obstet Gynecol 1995; 173:141-5.
  • 83. Peaceman A.M., Andrews W.W., Thorp J.M., et al. Fetal fibronectin as a predictor of preterm birth in patients with symptoms:a multicenter trial. Am J Obstet Gynecol 1997; 177:13-8.
  • 84. Pastore L.M., Royce R.A., Jackson T.P., et al. Association between bacterial vaginosis and fetal fibronectin at 24-29 weeks’ gestation. Obstet Gynecol 1999; 93:117-23.
  • 85. Goffeng A.R., Holst E., Milsom I. Fetal fibronectin and microorganisms in vaginal fluid of healthy pregnant women. Acta Obstet Gynecol Scand 1996; 75:520-5.
  • 86. Goldenberg R.L., Thom E., Moawad A.H., et al. The preterm prediction study:fetal fibronectin, bacterial vaginosis, and peripartum infection. Obstet Gynecol 1996; 87:656-60.
  • 87. Hitti J., Hillier S.L., Agnew K.J., et al. Vaginal indicators of amniotic fluid infection in preterm labour. Obstet Gynecol 2001; 97:211-9.
  • 88. Mattsby-Baltzer I., Platz-Christensen J.J., Hosseini N., Rosen P. IL-1β, IL-6, TNFα, fetal fibronectin, and endotoxin in the lower genital tract of pregnant women with bacterial vaginosis. Acta Obstet Gynecol Scand 1998; 77:701-6.
  • 89. Dinarello C.A., Wolff S.M. The role of interleukin-1 in disease. N Engl J Med 1993; 328:106-13.
  • 90. Pretorius C., Jagatt A., Lamont R.F. The relationship between periodontal disease, bacterial vaginosis, and preterm birth. J Perinat Med 2007; 35:93-9.
  • 91. Boggess K.A. Pathophysiology of preterm birth:emerging concepts of maternal infection. Clin Perinatol 2005; 32:561-9.
  • 92. Martin J.A., Hamilton B.E., Sutton P.D., et al. Births: final data for 2004. Natl Vital Stat Rep 2006; 55:1-101.
  • 93. McDonald H.M., O’Loughlin J.A., Vigneswaran R., et al. Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis):a randomized, placebo controlled trial. Br J Obstet Gynaecol 1997; 104:1391-7.
  • 94. Vermeulen G.M., Bruinse H.W. Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk:a randomized placebo-controlled double-blind trial. Br J Obstet Gynaecol 1999; 106:652-7.
  • 95. Lamont R.F. Antibiotics for the prevention of preterm birth. N Engl J Med 2000; 342:581-3.
  • 96. Brocklehurst P., Hannah M., McDonald H. Interventions for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2000; 2:CD000262.
  • 97. Goldenberg R.L. The management of preterm labor. Obstet Gynecol 2002; 100:1020-37.
  • 98. Okun N., Gronau K.A., Hannah M.E. Antibiotics for bacterial vaginosis or Trichomonas vaginalis in pregnancy:a systematic review. Obstet Gynecol 2005; 105:857-68.
  • 99. Duff P., Lee M., Hillier S., et al. Amoxicillin treatment of bacterial vaginosis during pregnancy. Obstet Gynecol 1991; 77:431-5.
  • 100. Odendaal H.J., Popov I., Schoeman J., et al. Preterm labour – is bacterial vaginosis involved? S Afr Med J 2002; 92:231-4.
  • 101. Klebanoff M., Carey J., Hauth J.C., et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001; 345:487-93.
  • 102. Andrews W.W., Sibai B.M., Thom, E.A., et al. Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet Gynecol 2003; 101:847-55.
  • 103. Guise J.M., Mahon S.M., Aickin M., et al. Screening for bacterial vaginosis in pregnancy. Am J Prevent Med 2001; 20(Suppl. 1):62-72.
  • 104. Goepfert A.R., Goldenberg R.L., Andrews W.W., et al. The preterm Prediction Study:association between cervical interleukin 6 concentration and spontaneous preterm birth. Am J Obstet Gynecol 2001; 184:483-8.
  • 105. Varma R., Gupta J.K. Antibiotic treatment of bacterial vaginosis in pregnancy:multiple meta-analyses and dilemmas in interpretation. Eur J Obstet Gynecol Reprod Biol 2006; 124:10-4.
  • 106. Kurkinen-Räty M., Vuopala S., Koskela M., et al. A randomized controlled trial of vaginal clindamycin for early pregnancy bacterial vaginosis. Br J Obstet Gynaecol 2000; 107:1427-32.
  • 107. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Morb Mortal Wkly Rep 2002; 51:1-82.
  • 108. Rosenstein I.J., Morgan D.J., Lamont R.F., et al. Effect of intravaginal clindamycin cream on pregnancy outcome and on abnormal vaginal microbial flora of pregnant women. Infect Dis Obstet Gynecol 2000; 8:158-65.
  • 109. Lamont R.F., Duncan S.L.B., Mandal D., Bassett P. Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract flora. Obstet Gynecol 2003; 101:516-22.
  • 110. Lamont R.F. Can antibiotics prevent preterm birth – the pro and con debate? Br J Obstet Gynaecol 2005; 112:67-73.
  • 111. Ugwumadu A., Manyonda I., Reid F., Hay P. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis:a randomized controlled trial. Lancet 2003; 361:983-8.
  • 112. Larsson P.G., Fahraeus L., Carlsson B., et al. Late miscarriage and preterm birth after treatment with clindamycin:a randomized consent design study according to Zelen. Br J Obstet Gynaecol 2006; 113:629-37.
  • 113. Morgan D.J., Taylor-Robinson D. Late miscarriage and preterm birth after treatment with clindamycin:a randomized consent design study according to Zelen. Br J Obstet Gynaecol 2006; 113:1483.
  • 114. Leitich H., Brunbauer M., Bodner-Adler B., et al. Antibiotic treatment of bacterial vaginosis in pregnancy: a meta-analysis. Am J Obstet Gynecol 2003; 188:752-8.
  • 115. Cotch M.F., Hillier S.L., Gibbs R.S., Eschenbach D.A. Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Am J Obstet Gynecol 1998; 178:374-80.
  • 116. Martin D., Eschenbach D., Cotch M., et al. Doubleblind placebo-controlled treatment trial of Chlamydia trachomatis endocervical infections in pregnant women. Infect Dis Obstet Gynecol 1997; 5:10-7.
  • 117. Gibbs R.S., Eschenbach D.A. Use of antibiotics to prevent preterm birth. Am J Obstet Gynecol 1997; 177:375- 80.
  • 118. Norman K., Pattinson R., de Souza J., et al. Ampicillin and metronidazole treatment in preterm labour:a multicentre randomized controlled trial. Br J Obstet Gynaecol 1994; 101:404-8.
  • 119. Svare J., Langhoff-Roos J., Anderson L.F., et al. Ampicillin-metronidazole treatment in idiopathic preterm labour:a randomised controlled multicentre trial. Br J Obstet Gynaecol 1997; 104:892-7.
  • 120. Eschenbach D.A., Nugent R.P., Rao A.V., et al. A randomized placebo-controlled trial of erythromycin for the treatment of Ureaplasma urealyticum to prevent premature delivery. Am J Obstet Gynecol 1991; 164:734-42.
  • 121. King J., Flenady V. Antibiotics for preterm labour with intact membranes. Cochrane Database Syst Rev 2001; 2: CD000246.
  • 122. Kenyon S.L., Taylor D.J., Tarnow-Mordi W. Broad spectrum antibiotics for spontaneous preterm labor:The ORACLE II randomized trial. Lancet 2001; 357:989-94.
  • 123. Kenyon S., Boulvain M. Antibiotics for preterm premature rupture of membranes. Cochrane Database Syst Rev 2001; 2:CD001058.
  • 124. Kenyon S.L., Taylor D.J., Tarnow-Mordi W. Antibiotics did not prevent adverse outcomes after preterm, prelabour of fetal membranes:The ORACLE I randomized trial. Lancet 2001; 357:979-88.
  • 125. Morency A.M., Bujold E. The effect of second-trimester antibiotic therapy on the rate of preterm birth. J Obstet Gynaecol Can 2007; 29:35-44.
  • 126. McDonald H., Brocklehurst P., Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy (Archive). Cochrane Database of Syst Rev 2007; 1:CD000262.
Views
0 Abstract
0 PDF
0 Crossref citations
Shared